» Articles » PMID: 31131395

Increased Tau Phosphorylation in Motor Neurons From Clinically Pure Sporadic Amyotrophic Lateral Sclerosis Patients

Overview
Specialties Neurology
Pathology
Date 2019 May 28
PMID 31131395
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Amyotrophic lateral sclerosis (ALS) is characterized by the progressive degeneration of motor neurons. There is a pathological and genetic link between ALS and frontotemporal lobar degeneration (FTLD). Although FTLD is characterized by abnormal phosphorylated tau deposition, it is unknown whether tau is phosphorylated in ALS motor neurons. Therefore, this study assessed tau epitopes that are commonly phosphorylated in FTLD, including serine 396 (pS396), 214 (pS214), and 404 (pS404) in motor neurons from clinically pure sporadic ALS cases compared with controls. In ALS lower motor neurons, tau pS396 was observed in the nucleus or the nucleus and cytoplasm. In ALS upper motor neurons, tau pS396 was observed in the nucleus, cytoplasm, or both the nucleus and cytoplasm. Tau pS214 and pS404 was observed only in the cytoplasm of upper and lower motor neurons in ALS. The number of motor neurons (per mm2) positive for tau pS396 and pS214, but not pS404, was significantly increased in ALS. Furthermore, there was a significant loss of phosphorylated tau-negative motor neurons in ALS compared with controls. Together, our data identified a complex relationship between motor neurons positive for tau phosphorylated at specific residues and disease duration, suggesting that tau phosphorylation plays a role in ALS.

Citing Articles

Phosphorylated tau 181 and 217 are elevated in serum and muscle of patients with amyotrophic lateral sclerosis.

Abu-Rumeileh S, Scholle L, Mensch A, Grosskopf H, Ratti A, Kolsch A Nat Commun. 2025; 16(1):2019.

PMID: 40044663 PMC: 11882981. DOI: 10.1038/s41467-025-57144-7.


Identifying dysregulated regions in amyotrophic lateral sclerosis through chromatin accessibility outliers.

Celik M, Gagneur J, Lim R, Wu J, Thompson L, Xie X HGG Adv. 2024; 5(3):100318.

PMID: 38872308 PMC: 11260578. DOI: 10.1016/j.xhgg.2024.100318.


Novel avenues of tau research.

Sexton C, Bitan G, Bowles K, Brys M, Buee L, Maina M Alzheimers Dement. 2024; 20(3):2240-2261.

PMID: 38170841 PMC: 10984447. DOI: 10.1002/alz.13533.


Mendelian Randomization Identifies Genetically Supported Drug Targets for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.

Zhu Y, Li M, Wang H, Yang F, Du R, Pang X Mol Neurobiol. 2023; 61(7):3809-3818.

PMID: 38019415 DOI: 10.1007/s12035-023-03817-7.


TDP-43 Proteinopathy and Tauopathy: Do They Have Pathomechanistic Links?.

Riku Y, Yoshida M, Iwasaki Y, Sobue G, Katsuno M, Ishigaki S Int J Mol Sci. 2022; 23(24).

PMID: 36555399 PMC: 9779029. DOI: 10.3390/ijms232415755.


References
1.
Al-Chalabi A, Hardiman O, Kiernan M, Chio A, Rix-Brooks B, van den Berg L . Amyotrophic lateral sclerosis: moving towards a new classification system. Lancet Neurol. 2016; 15(11):1182-94. DOI: 10.1016/S1474-4422(16)30199-5. View

2.
Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, Byrne S . The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry. 2011; 83(1):102-8. DOI: 10.1136/jnnp-2011-300188. View

3.
Naini S, Soussi-Yanicostas N . Tau Hyperphosphorylation and Oxidative Stress, a Critical Vicious Circle in Neurodegenerative Tauopathies?. Oxid Med Cell Longev. 2015; 2015:151979. PMC: 4630413. DOI: 10.1155/2015/151979. View

4.
Noel A, Barrier L, Ingrand S . The Tyr216 phosphorylated form of GSK3β contributes to tau phosphorylation at PHF-1 epitope in response to Aβ in the nucleus of SH-SY5Y cells. Life Sci. 2016; 158:14-21. DOI: 10.1016/j.lfs.2016.06.020. View

5.
Gotz J, Chen F, Van Dorpe J, Nitsch R . Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science. 2001; 293(5534):1491-5. DOI: 10.1126/science.1062097. View